Financial comparisons CorMedix Inc.

Stocks

Market Closed - Nasdaq Other stock markets 01:30:00 18/07/2026 am IST			5-day change	1st Jan Change
8.420 ^USD	+1.57%		+0.24%	-27.60%

07/07	RBC Capital Trims CorMedix Price Target to $13 From $14, Maintains Outperform Rating	MT
03/07	CorMedix Names Elizabeth Hurlburt as Chief Operating, Commercial Officer	MT

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Revenues (N-1)	Net Margin (N-1)	EBIT Margin (N-1)	ROE (N-1)	ROA (N-1)	Leverage (N-1)
CORMEDIX INC.	31Cr	52.31%	48.17%	-	-	-0.02x
MERCK & CO., INC.	6.5TCr	28.08%	41.19%	45.52%	17.73%	1.07x
MERCK KGAA	2.48TCr	12.36%	17.06%	12.4%	5.06%	1.51x
HALOZYME THERAPEUTICS, INC.	139.66Cr	22.69%	33.58%	153.59%	-	3.59x
KYOWA KIRIN CO., LTD.	316.88Cr	13.49%	20.59%	7.7%	8.02%	-1.69x
SK BIOPHARMACEUTICALS CO., LTD.	49Cr	37.77%	28.86%	39.28%	22.66%	-1.18x
BETTA PHARMACEUTICALS CO., LTD.	52Cr	8.46%	11.59%	5.02%	-	2.04x
YUHAN CORPORATION	151.48Cr	8.48%	4.77%	8.21%	6.3%	-0.32x
SUPERNUS PHARMACEUTICALS, INC.	72Cr	-5.36%	22.07%	12.89%	-	-
KISSEI PHARMACEUTICAL CO., LTD.	61Cr	14.15%	-3%	6.3%	-0.45%	-30.97x
ETON PHARMACEUTICALS, INC.	8Cr	-5.75%	-1.06%	-	-	-
DBV TECHNOLOGIES	57.37L	-2,607.29%	-2,609.23%	-149.83%	-	1.35x
Average	821.68Cr	-201.72%	-198.78%	14.11%	9.89%	-2.46x
Weighted average by Cap.	5.31TCr	19.02%	30.08%	40.28%	15.28%	1.03x